Eli Lilly’s alopecia drug Olumiant off to positive start with doctors, Spherix research finds
Eli Lilly’s alopecia areata drug is off to a good start with dermatologists. So good, in fact, that the launch of Olumiant in alopecia looks …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
